These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

779 related items for PubMed ID: 17407130

  • 1. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A, Ma PC, Salgia R.
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [Abstract] [Full Text] [Related]

  • 2. Circulating tumor cells and serum tumor biomarkers in small cell lung cancer.
    Ma PC, Blaszkowsky L, Bharti A, Ladanyi A, Kraeft SK, Bruno A, Skarin AT, Chen LB, Salgia R.
    Anticancer Res; 2003; 23(1A):49-62. PubMed ID: 12683352
    [Abstract] [Full Text] [Related]

  • 3. Biomarkers for lung cancer: clinical uses.
    Greenberg AK, Lee MS.
    Curr Opin Pulm Med; 2007 Jul; 13(4):249-55. PubMed ID: 17534168
    [Abstract] [Full Text] [Related]

  • 4. Proteomic approaches in lung cancer biomarker development.
    Cho JY, Sung HJ.
    Expert Rev Proteomics; 2009 Feb; 6(1):27-42. PubMed ID: 19210125
    [Abstract] [Full Text] [Related]

  • 5. Clinical proteomics in breast cancer: a review.
    Gast MC, Schellens JH, Beijnen JH.
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [Abstract] [Full Text] [Related]

  • 6. Markers of small cell lung cancer.
    Taneja TK, Sharma SK.
    World J Surg Oncol; 2004 May 05; 2():10. PubMed ID: 15128454
    [Abstract] [Full Text] [Related]

  • 7. Present status of clinical proteomic analysis for the early detection and determination of therapeutic strategy in lung cancer.
    Hirano T, Kato H.
    Ann Thorac Cardiovasc Surg; 2006 Feb 05; 12(1):4-9. PubMed ID: 16572067
    [Abstract] [Full Text] [Related]

  • 8. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.
    Kulasingam V, Diamandis EP.
    Nat Clin Pract Oncol; 2008 Oct 05; 5(10):588-99. PubMed ID: 18695711
    [Abstract] [Full Text] [Related]

  • 9. Proteomics analysis in lung cancer: challenges and opportunities.
    Kikuchi T, Carbone DP.
    Respirology; 2007 Jan 05; 12(1):22-8. PubMed ID: 17207021
    [Abstract] [Full Text] [Related]

  • 10. Proteomics in prostate cancer biomarker discovery.
    Larkin SE, Zeidan B, Taylor MG, Bickers B, Al-Ruwaili J, Aukim-Hastie C, Townsend PA.
    Expert Rev Proteomics; 2010 Feb 05; 7(1):93-102. PubMed ID: 20121479
    [Abstract] [Full Text] [Related]

  • 11. Proteomics and the haematologist.
    Rees-Unwin KS, Morgan GJ, Davies FE.
    Clin Lab Haematol; 2004 Apr 05; 26(2):77-86. PubMed ID: 15053800
    [Abstract] [Full Text] [Related]

  • 12. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
    Ueda K, Katagiri T, Shimada T, Irie S, Sato TA, Nakamura Y, Daigo Y.
    J Proteome Res; 2007 Sep 05; 6(9):3475-83. PubMed ID: 17705522
    [Abstract] [Full Text] [Related]

  • 13. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR, Liotta LA, Petricoin EF.
    Biosci Rep; 2005 Sep 05; 25(1-2):107-25. PubMed ID: 16222423
    [Abstract] [Full Text] [Related]

  • 14. Advanced proteomic technologies for cancer biomarker discovery.
    Wong SC, Chan CM, Ma BB, Lam MY, Choi GC, Au TC, Chan AS, Chan AT.
    Expert Rev Proteomics; 2009 Apr 05; 6(2):123-34. PubMed ID: 19385940
    [Abstract] [Full Text] [Related]

  • 15. Oncoproteomics: current trends and future perspectives.
    Cho WC, Cheng CH.
    Expert Rev Proteomics; 2007 Jun 05; 4(3):401-10. PubMed ID: 17552924
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
    Matta A, Ralhan R, DeSouza LV, Siu KW.
    Mass Spectrom Rev; 2010 Jun 05; 29(6):945-61. PubMed ID: 20945361
    [Abstract] [Full Text] [Related]

  • 18. Clinical proteomics and mass spectrometry profiling for cancer detection.
    Solassol J, Jacot W, Lhermitte L, Boulle N, Maudelonde T, Mangé A.
    Expert Rev Proteomics; 2006 Jun 05; 3(3):311-20. PubMed ID: 16771703
    [Abstract] [Full Text] [Related]

  • 19. Clinical cancer proteomics: promises and pitfalls.
    Alaiya A, Al-Mohanna M, Linder S.
    J Proteome Res; 2005 Jun 05; 4(4):1213-22. PubMed ID: 16083271
    [Abstract] [Full Text] [Related]

  • 20. Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.
    Jurisicova A, Jurisica I, Kislinger T.
    Expert Rev Proteomics; 2008 Aug 05; 5(4):551-60. PubMed ID: 18761466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.